Kim Kelderman - 15 Aug 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
PRES. DIAGNOSTICS & GENOM
Signature
/s/ Brenda S. Furlow, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed
Issuer symbol
TECH
Transactions as of
15 Aug 2022
Net transactions value
$0
Form type
4
Filing time
17 Aug 2022, 17:25:16 UTC
Previous filing
09 Aug 2022
Next filing
25 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TECH Common Stock 3,138 15 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Award $0 +1,746 $0.000000 1,746 15 Aug 2022 Common Stock 1,746 Direct F1, F2
transaction TECH Stock Options (Right to Buy) Award $0 +5,426 $0.000000 5,426 15 Aug 2022 Common Stock 5,426 $378.08 Direct F2
transaction TECH Stock Options (Right to Buy) Award $0 +7,235 $0.000000 7,235 15 Aug 2022 Common Stock 7,235 $378.08 Direct F3
holding TECH Stock Options (Right to Buy) 7,511 15 Aug 2022 Common Stock 7,511 $150.78 Direct F4
holding TECH Stock Options (Right to Buy) 12,044 15 Aug 2022 Common Stock 12,044 $177.32 Direct F5
holding TECH Stock Options (Right to Buy) 9,033 15 Aug 2022 Common Stock 9,033 $177.32 Direct F6
holding TECH Stock Options (Right to Buy) 11,961 15 Aug 2022 Common Stock 11,961 $190.41 Direct F7
holding TECH Stock Options (Right to Buy) 15,948 15 Aug 2022 Common Stock 15,948 $190.41 Direct F8
holding TECH Restricted Stock Units 2,015 15 Aug 2022 Common Stock 2,015 Direct F1, F2
holding TECH Stock Options (Right to Buy) 8,991 15 Aug 2022 Common Stock 8,991 $267.87 Direct F2
holding TECH Stock Options (Right to Buy) 11,988 15 Aug 2022 Common Stock 11,988 $267.87 Direct F9
holding TECH Stock Options (Right to Buy) 8,325 15 Aug 2022 Common Stock 8,325 $267.87 Direct F10
holding TECH Stock Options (Right to Buy) 8,325 15 Aug 2022 Common Stock 8,325 $267.87 Direct F11
holding TECH Restricted Stock Units 1,245 15 Aug 2022 Common Stock 1,245 Direct F1, F12
holding TECH Stock Options (Right to Buy) 6,486 15 Aug 2022 Common Stock 6,486 $481.82 Direct F13
holding TECH Stock Options (Right to Buy) 4,864 15 Aug 2022 Common Stock 4,864 $481.82 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2 Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F3 Options to purchase 1,809 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 1,808 shares vest on 8/15/2025.
F4 Options to purchase 2,500 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
F5 Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.
F6 Fully exercisable.
F7 On 8/7/2022, the Board of Directors certified vesting of 2,363 performance shares.
F8 Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
F9 Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F10 Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F11 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F12 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F13 Options to purchase 1,621 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,622 shares vest on each of 8/6/2024 and 8/6/2025.